Phenotypic Manifestations of Hereditary ATTR Amyloidosis Val50Met Variant in a Non-endemic Area. Descriptive Study
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test, Other
Study Type: Observational
SUMMARY
This study focuses on hereditary transthyretin amyloidosis (ATTRv) with the Val50Met variant in a non endemic aerea
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: f
View:
• All subjects between 20 and 70 years of age, carriers of the Val50Met variant
Locations
Other Locations
Argentina
Hospital las Breñas 9 de Julio
ENROLLING_BY_INVITATION
Charata
Hosptial Las Breñas
RECRUITING
Charata
Contact Information
Primary
Mauricio MT TOMEI, MD
mht10@hotmail.com
+5493731558832
Time Frame
Start Date: 2024-09-01
Estimated Completion Date: 2027-03-01
Participants
Target number of participants: 57
Treatments
Carriers of the Val50Met variant
Patients with positive genetic test for patogenic variant of the TTR gene
Related Therapeutic Areas
Sponsors
Collaborators: Instituto de Cardiología de Corrientes
Leads: Hospital 9 de Julio de Las Breñas